Rule 8 - Cambridge Antibody Technology Group plc
April 03 2003 - 10:00AM
UK Regulatory
BW20030403002039 20030403T150006Z UTC
( BW)(WELLINGTON-MANAGEMENT)(CAT) Rule 8 - Cambridge Antibody
Technology Group plc
Business Editors
UK REGULATORY NEWS
BOSTON--(BUSINESS WIRE)--April 3, 2003--
DISCLOSURE UNDER RULES 8.1/8.3
Lodge with a RIS or Newstrack and the Takeover Panel. Use separate
form for each class of securities in which dealings have been made.
Date of disclosure...3 April, 2003
DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) AND 8.3
OF THE CITY CODE ON TAKEOVERS AND MERGERS
Date of dealing...2 April, 2003
Dealing in...Cambridge Antibody Technology Group plc.............(name of company)
(1) Class of securities (eg ordinary shares)..........Ordinary shares
(2) Amount bought Amount sold Price per unit
219,664 3.3000
(3) Resultant total of the same 1,982,000.............................................(5.45%)
(4) Party making disclosure .Wellington Management Company, LLP
(5) EITHER (a)Name of purchaser/vendor (Note 1)...................................................
OR (b)If dealing for discretionary client(s), name of fund management organisation
Wellington Management Company, LLP
(6) Reason for disclosure (Note 2)
(a) associate of (i) offeror (Note 3)
NO
(ii) offeree company NO
Specify which category or categories of associate (1-8 overleaf) ............................
If category (8), explain..........................................................................
(b) Rule 8.3 (ie disclosure because of ownership or control of 1% or more of
the class of relevant securities dealt in)
YES
Signed, for and on behalf of the party named in (4) above....................................
(Also print name of signatory) Brian P. Hillery
Telephone and extension number 617-790-7747
Note 1. Specify owner, not nominee or vehicle company. If relevant,
also identify controller of owner, eg where an owner normally
acts on instructions of a controller.
Note 2. Disclosure might be made for more than one reason; if so,
state all reasons. Note 3. Specify which offeror if there is more than
one.
Note 4. When an arrangement exists with any offeror, with the
offeree company or with an associate of any offeror or of the
offeree company in relation to relevant securities, details of
such arrangement must be disclosed, as required by Note 6 on
Rule 8.
Note 5. It may be necessary, particularly when disclosing
derivative transactions, to append a sheet to this disclosure
form so that all relevant information can be given.
Note 6. In the case of an average price bargain, each underlying trade
should be disclosed.
For full details of disclosure requirements, see Rule 8 of the Code.
If in doubt, contact the Panel on Takeovers and Mergers, Monitoring
Section, Tel. No: 020 7638 0129. E-mail:monitoring@disclosure.org.uk
Short Name: Wellington Management
Category Code: DCC
Sequence Number: 00003612
Time of Receipt (offset from UTC): 20030403T155620+0100
--30--mh/uk*
CONTACT: Wellington Management
KEYWORD: MASSACHUSETTS UNITED KINGDOM INTERNATIONAL EUROPE
INDUSTRY KEYWORD: BANKING
SOURCE: Wellington Management
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: http://www.businesswire.com